Announced
Completed
Synopsis
Philogen, a biotech company that develops biotech products for the imaging and therapy of life, completed the merger with Palio Ordinarie in a $596m deal. This merger made it possible to dissolve the vehicle Palio Ordinarie, contributing towards the generation of a free float equal to 17% for the listing process.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.